Accessed on 22.04.2023 To target helminth elimination, a new consortium of research institutes, universities, not-for-profit organizations, and pharmaceutical companies have joined forces and expertise to establish a research and development pipeline for the development of anthelminthics targeting nematodes. The focus is on STH as well as onchocerciasis.